scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M607712200 |
P698 | PubMed publication ID | 17220301 |
P2093 | author name string | Tushar Patel | |
Heather Smith | |||
Yoshiyuki Ueno | |||
Fanyin Meng | |||
Hania Wehbe-Janek | |||
Roger Henson | |||
P2860 | cites work | Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling | Q24319849 |
RAS is regulated by the let-7 microRNA family | Q27860522 | ||
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 | ||
A microRNA polycistron as a potential human oncogene | Q27860720 | ||
Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
MicroRNA expression profiles classify human cancers | Q28032481 | ||
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells | Q28237683 | ||
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
Specificity of microRNA target selection in translational repression | Q28776123 | ||
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines | Q28975767 | ||
The colorectal microRNAome | Q29616082 | ||
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors | Q33941380 | ||
Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes | Q34881846 | ||
The role of IL-6 and STAT3 in inflammation and cancer | Q36274467 | ||
Prediction and validation of microRNAs and their targets | Q36281297 | ||
Gene regulation by microRNAs | Q36406938 | ||
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis | Q37486563 | ||
Evaluation of potential Stat3-regulated genes in human breast cancer | Q38322580 | ||
Membrane-associated STAT3 and PY-STAT3 in the cytoplasm. | Q40331313 | ||
Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells | Q40345898 | ||
Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis | Q40832782 | ||
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells | Q40972355 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interleukins | Q194908 |
microRNA | Q310899 | ||
P304 | page(s) | 8256-8264 | |
P577 | publication date | 2007-01-12 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. | |
P478 | volume | 282 |
Q35562369 | A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma. |
Q36411472 | A six-microRNA set as prognostic indicators for bile duct cancer |
Q37878880 | Aberrant DNA methylation profile in cholangiocarcinoma |
Q39881903 | Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1. |
Q35655840 | Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis |
Q38228503 | Autophagy and microRNA dysregulation in liver diseases |
Q35953283 | Clinical and subclinical endometritis induced alterations in bovine endometrial transcriptome and miRNome profile |
Q36250109 | Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. |
Q36130078 | Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma |
Q36406800 | Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer |
Q45883493 | Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance |
Q37275739 | Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin |
Q35191416 | Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein |
Q37798161 | Desperately seeking microRNA targets |
Q36224976 | Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation |
Q39318958 | Dynamic regulation of microRNA expression following interferon-γ-induced gene transcription. |
Q34200081 | Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma |
Q38642455 | Emerging molecular targets and therapy for cholangiocarcinoma |
Q24624514 | Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7 |
Q37306838 | Epigenetic modifications in rheumatoid arthritis |
Q46608275 | Epigenetic role of miRNAs in normal and leukemic hematopoiesis |
Q35048239 | Functional analysis of microRNAs in human hepatocellular cancer stem cells |
Q37045820 | Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs |
Q27005787 | Genetic profiling of intrahepatic cholangiocarcinoma |
Q34412371 | Genomic DNA copy-number alterations of the let-7 family in human cancers |
Q36051517 | High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease |
Q33889122 | IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells |
Q34838128 | Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis |
Q28394212 | Impact of pyrrolidine dithiocarbamate and interleukin-6 on mammalian target of rapamycin complex 1 regulation and global protein translation |
Q33372109 | Interfering RNA and HIV: reciprocal interferences |
Q36938072 | Interleukin-6 and its receptor in cancer: implications for translational therapeutics |
Q34399321 | Lactation-related microRNA expression profiles of porcine breast milk exosomes |
Q39789168 | Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells |
Q37640216 | Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk |
Q36955306 | Lin28 and let-7: roles and regulation in liver diseases. |
Q34428326 | Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion |
Q58704736 | Mechanistic evidence that benzo[a]pyrene promotes an inflammatory microenvironment that drives the metastatic potential of human mammary cells |
Q44139838 | MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma |
Q37238372 | MiRNAs, epigenetics, and cancer |
Q37751868 | MicroRNA and drug resistance |
Q33926927 | MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes |
Q39015995 | MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. |
Q28510366 | MicroRNA expression and regulation in mouse uterus during embryo implantation |
Q39580400 | MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts. |
Q81345831 | MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors |
Q85541574 | MicroRNA let-7a ameliorates con A-induced hepatitis by inhibiting IL-6-dependent Th17 cell differentiation |
Q37388413 | MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer |
Q28475999 | MicroRNA signature and regulatory functions in the endometrium during normal and disease states |
Q38509951 | MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications |
Q27488310 | MicroRNA signatures in liver diseases |
Q34895116 | MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. |
Q34228326 | MicroRNA-22 can reduce parathymosin expression in transdifferentiated hepatocytes |
Q35601698 | MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro |
Q34878670 | MicroRNA: A matter of life or death |
Q26865762 | MicroRNAs and benign biliary tract diseases |
Q36324033 | MicroRNAs in Breastmilk and the Lactating Breast: Potential Immunoprotectors and Developmental Regulators for the Infant and the Mother |
Q33991899 | MicroRNAs in Cholangiopathies |
Q37981158 | MicroRNAs in Hepatobiliary and Pancreatic Cancers |
Q36410357 | MicroRNAs in biliary diseases. |
Q30437444 | MicroRNAs in cancer |
Q26783579 | MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment |
Q37287182 | MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death |
Q99548917 | Milk Exosomes: Perspective Agents for Anticancer Drug Delivery |
Q39605990 | Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. |
Q37371743 | Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes |
Q92269858 | Modulation of biliary cancer chemo-resistance through microRNA-mediated rewiring of the expansion of CD133+ cells |
Q35820533 | Molecular Targets in Biliary Carcinogenesis and Implications for Therapy |
Q37878879 | Molecular mechanisms of cholangiocarcinoma |
Q47153848 | NcRNAs and Cholangiocarcinoma |
Q37280624 | Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression |
Q36951319 | OncomiRs: the discovery and progress of microRNAs in cancers |
Q58557374 | Preliminary study on the effect of nucleolin specific aptamer-miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells |
Q36879784 | RISCy business: MicroRNAs, pathogenesis, and viruses |
Q41977319 | Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors |
Q33994814 | Recent advances in the regulation of cholangiocarcinoma growth |
Q41890041 | Role of miRNA let-7 and its major targets in prostate cancer. |
Q26770485 | Role of microRNAs in chemoresistance |
Q39471126 | Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regeneration |
Q38346740 | Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells |
Q36210966 | Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma |
Q38156148 | Small RNA regulation of reproductive function |
Q38547893 | Small RNAs: Their Possible Roles in Reproductive Failure |
Q36683019 | The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer |
Q37262636 | The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma |
Q38257098 | The impact of hepatitis B virus x protein and microRNAs in hepatocellular carcinoma: a comprehensive analysis |
Q34356918 | The myriad essential roles of microRNAs in cardiovascular homeostasis and disease |
Q26865749 | The significance of genetics for cholangiocarcinoma development |
Q38210867 | Therapeutic potential of microRNA let-7: tumor suppression or impeding normal stemness. |
Q59800406 | Toll-Like Receptor and miRNA-let-7e Expression Alter the Inflammatory Response in Leishmania amazonensis-Infected Macrophages |
Q36070235 | Tumor-suppressive effects of atelocollagen-conjugated hsa-miR-520d-5p on un-differentiated cancer cells in a mouse xenograft model |
Q35746187 | Uterine microRNA signature and consequence of their dysregulation in uterine disorders. |
Q37225736 | Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma |
Q91741405 | Xeno-miRNA in Maternal-Infant Immune Crosstalk: An Aid to Disease Alleviation |
Q39638471 | miR-1228 prevents cellular apoptosis through targeting of MOAP1 protein |
Q28303576 | miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation |
Q34241503 | miR-93 suppresses proliferation and colony formation of human colon cancer stem cells |
Q53099936 | miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma. |
Q35086852 | miRNA regulation of cytokine genes |
Q36224336 | microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer |
Q38921257 | microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6. |
Search more.